Vertex Pharmaceuticals Acquisitions
Vertex Pharmaceuticals has acquired 9 companies and its latest acquisition was Crinetics Pharmaceuticals, Inc. on Jul 2026
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Crinetics Pharmaceuticals, Inc.
Jul 2026
Source »$10B
Crinetics is a California-based pharmaceutical company that researches and develops novel therapeutics for the treatment of endocrine diseases.
Alpine Immune Sciences, Inc.
Apr 2024
Source »$4.9B
Alpine is a Washington-based biotechnology company that researches and develops protein-based immunotherapies for the treatment of cancer and autoimmune diseases.
ViaCyte, Inc.
Jul 2022
Source »$320M
ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.
Frequently Asked Questions about Vertex Pharmaceuticals
What companies did Vertex Pharmaceuticals acquire?
Companies acquired by Vertex Pharmaceuticals include Crinetics, Alpine and ViaCyteHow many acquisitions does Vertex Pharmaceuticals have?
Vertex Pharmaceuticals has acquired 9 companies including Crinetics, Alpine and ViaCyte.
How many acquisitions did Vertex Pharmaceuticals make in 2026?
In 2026 Vertex Pharmaceuticals acquired 1 companies including Crinetics.